Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
DRUG compared with PRAX: revenue, margins and what each company keeps, and the suppliers and customers both name
DRUG
Bright Minds Biosciences Inc.
Change
Mkt cap
Revenue
Revenue
PRAX
Praxis Precision Medicines, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
DRUG
Bright Minds Biosciences Inc.
vs
PRAX
Praxis Precision Medicines, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
DRUG
No earnings history for DRUG.
PRAX
1 of 4
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
±9.4%
▲
+15.95%
×1.69
Q1 FY26
±7.4%
▼
−0.98%
×0.14
Feb 19 '26
±7.3%
▲
+0.81%
×0.11
Q3 FY25
±12.1%
▼
−4.14%
×0.34
= implied
DRUG realized, solid
PRAX realized, hatched
One scale, both sides: full bar = 16%
× = |realized| ÷ implied
Source: market data
DRUG
Bright Minds Biosciences Inc.
Change
21.99
▲
+6.22%
Mkt cap
$158.1M
Revenue
—
Revenue
—
PRAX
Praxis Precision Medicines, Inc.
Change
271.40
▲
+3.35%
Regular session
Nov 6 '26
Mkt cap
$7.3B
Revenue
$7M
Q4 FY24
Revenue
$9M
FY24
vs
Compare
Regular session
Nov 6 '26
DRUG
Bright Minds Biosciences Inc.
vs
PRAX
Praxis Precision Medicines, Inc.
21.99
▲
+6.22%
Price
271.40
▲
+3.35%
$158.1M
Mkt cap
$7.3B
—
Revenue
$7M
Q4 FY24
—
Revenue
$9M
FY24
Change
Change
DRUG
21.99
▲
+6.22%
vs
PRAX
271.40
▲
+3.35%
Regular session
Nov 6 '26